Please assess the completion status of the following clinical trial:

Trial Title: Study of Levofloxacin-based Concomitant Therapy for H. Pylori Eradication in Diabetic Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diabetic patients with Helicobacter pylori infection~Exclusion Criteria:~* Pregnancy or physically poor performance status~* Patients with contraindication for upper endoscopy~* Severe coagulopathy for endoscopic biopsy~* Chronic kidney disease (eGFR \< 50) or end stage renal disease~* Known allergy to interventional drugs~* Previous eradication failure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Levofloxacin-based concomitant (Type: EXPERIMENTAL): Pantoprazole 40 mg BID day1\~day10 Amoxicillin 1000 mg BID day1\~day10 Metronidazole 500 mg BID day1\~day10 Levofloxacin 500 mg QD day1\~day10
- Sequential (Type: ACTIVE_COMPARATOR): Pantoprazole 40 mg BID day1\~day10 Amoxicillin 1000 mg BID day1\~day5 Metronidazole 500 mg BID day6\~day10 Clarithromycin 500 mg BID day6\~day10

Based on this trial design, predict the completion outcome and termination type (if applicable).